A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trial

This publication has 47 references indexed in Scilit:

• Factors associated with severe infection in rheumatoid arthritis patients: lessons learned from the COVID-19 pandemic
  Infection, 2024
• Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
  The Lancet, 2024
• Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
  JAMA, 2023
• Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index
  ACR Open Rheumatology, 2021
• Rheumatoid Factor as a Potentiator of Anti–Citrullinated Protein Antibody–Mediated Inflammation in Rheumatoid Arthritis
  Arthritis & Rheumatology, 2014
• HLA shared epitope and ACPA: Just a marker or an active player?
  Autoimmunity Reviews, 2013
• Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
  Clinical Rheumatology, 2013
• Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
  Arthritis & Rheumatism, 2012
• Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis
  Arthritis Care & Research, 2009
• The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
  Arthritis & Rheumatism, 1987